Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Sizing Up the CDMO Market

A new analysis highlights growth drivers and challenges for clinical supply-chain services.
Oct 2, 2009

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Expansion Plan

Contract-service providers are expanding their offerings in this slow-growth environment.
Sep 2, 2009

Contract-service providers are expanding their offerings in this slow-growth environment.

Step Carefully into Foreign Affairs

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.
Sep 1, 2009

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

Expansion plan

Sep 1, 2009

In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.

Step Carefully into Foreign Affairs

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.
Aug 2, 2009

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

Industry Outlook: Down But Not Out

The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.
Aug 1, 2009

The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.

Issue Extra: Executive Roundtable—The Future of Pharmaceutical CMC Outsourcing

A Q&A with Pfizer CentreSource, moderated by Jim Miller.
Aug 1, 2009

A Q&A with Pfizer CentreSource, moderated by Jim Miller.

The Future of Pharmaceutical CMC Outsourcing

A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.
Aug 1, 2009

A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.

Penny-Wise, Pound-Foolish

Pharma companies that sell redundant facilities could endanger their supply chains.
Jul 8, 2009

Pharma companies that sell redundant facilities could endanger their supply chains.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here